Volume 18, Number 9—September 2012
CME ACTIVITY - Research
Evaluation of Diagnostic and Therapeutic Approaches for Suspected Influenza A(H1N1)pdm09 Infection, 2009–2010
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: August 21, 2012; Expiration date: August 21, 2013
Upon completion of this activity, participants will be able to:
• Analyze the use of diagnostic testing in cases of influenza-like illness
• Evaluate the use of antiviral medications for outpatient cases of influenza-like illness
• Evaluate the use of antiviral medications for inpatient cases of influenza-like illness
• Assess the care of patients with influenza-like illness and lower respiratory tract infections
Carol E. Snarey, MA, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Carol E. Snarey, MA, has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Vini Vijayan, MD; and Jennie Jing, MS, have disclosed no relevant financial relationships. Kenneth Zangwill, MD, has disclosed the following relevant financial relationships: served as an advisor or consultant for Merck & Co. Inc.; received grants for clinical research from Novartis.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: August 22, 2012
- Page last updated: August 22, 2012
- Page last reviewed: August 22, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)